carbamazepine has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, CW | 1 |
| Zhang, H | 1 |
| Li, M | 1 |
| Xiong, X | 1 |
| Chen, X | 2 |
| Dong, XC | 1 |
| Yin, XM | 1 |
| Friedman, SL | 1 |
2 other studies available for carbamazepine and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice.
Topics: Animals; Autophagy; Biomarkers; Carbamazepine; Cells, Cultured; Chloroquine; Dietary Fats; Disease M | 2013 |
Focus.
Topics: Animals; Autophagy; Carbamazepine; Fatty Liver; Fatty Liver, Alcoholic; Non-alcoholic Fatty Liver Di | 2013 |